Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More

Quidel: Robert Bujarski

Quidel has appointed Robert Bujarski as chief operating officer effective Sept. 14. Bujarski had been Quidel's SVP of commercial operations in North America and general counsel since July 2019, SVP of business development from August 2009 through July 2019, and corporate secretary until February 2019.


NeoGenomics: Madhushree Ghosh

NeoGenomics announced that Madhushree Ghosh has joined the company as VP of alliances and companion diagnostics. She previously served as the senior director of strategic accounts and global strategic partnerships at Thermo Fisher Scientific. She has also served as VP of alliance management and VP of the research services business unit at Althea Dx, as well as in senior leadership positions at Qiagen and Enigma Diagnostics. Ghosh has expertise in next-generation sequencing, multiplex and real-time PCR, oncology, and infectious diseases.


Veracyte: Richard Kloos

Veracyte has promoted Richard Kloos to executive medical director, overseeing the company's global medical affairs in all clinical areas addressed by its genomic tests. Kloos previously served as senior medical director of endocrinology at Veracyte, which he joined in 2012. He was previously a professor of endocrinology and metabolism, and nuclear medicine at Ohio State University, and was attending physician at the OSU Comprehensive Care Center. He was also codirector of the OSU Thyroid Cancer Unit and served a four-year term as secretary and chief operating officer for the American Thyroid Association.


For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.